http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2024257-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16ab283be9883506ca41e5579f9acee8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 |
| filingDate | 1986-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1994-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7fdf5dc5b4348e7f381fd200609a0d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_653e3994649615e59d6d284fd10817b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5951631ba8af15cb7fe2a008be6397d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72cc6ceb6bbb718bd7645f90da8b75f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_274cfa16999b3feff34991b3028b4abd |
| publicationDate | 1994-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2024257-C1 |
| titleOfInvention | Immunomodulating agent |
| abstract | FIELD: new medical agent intended to normalize immune status of organism. SUBSTANCE: antiinflammatory and antimicrobial agent - chlobasol - is used in the capacity of immunomodulator, particularly for treatment of chronic bronchitis with derangements of immune status. Chlobasol is administered at the rate of one tablet (0.1 g) three times a day for 14 days. As compared with known immunomodulator (levamisol), chlobasol features not only immunocorrecting but also antiinflammatory and antimicrobial effect. As distinct from levamisol, it is not toxic. EFFECT: new antiinflammatory and antimicrobial agent - chlobasol - is used in a new function, as immunomodulator. |
| priorityDate | 1986-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.